Literature DB >> 27028505

Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.

M Megna1, M Napolitano2, N Balato2, G Monfrecola2, A Villani2, F Ayala2, A Balato2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27028505     DOI： 10.1111/ced.12850

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  10 in total

1.  Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study.

Authors:  Maddalena Napolitano; Luisa Costa; Francesco Caso; Matteo Megna; Raffaele Scarpa; Nicola Balato; Fabio Ayala; Anna Balato
Journal:  Clin Rheumatol       Date:  2017-05-31       Impact factor: 2.980

2.  Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice.

Authors:  A Ruggiero; G Fabbrocini; E Cinelli; S S Ocampo Garza; E Camela; M Megna
Journal:  Clin Exp Dermatol       Date:  2021-11-17       Impact factor: 4.481

Review 3.  Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist.

Authors:  Luigi Barrea; Maria Cristina Savanelli; Carolina Di Somma; Maddalena Napolitano; Matteo Megna; Annamaria Colao; Silvia Savastano
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

Review 4.  Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape.

Authors:  Jean-Frédéric LeBlanc; Daniel Wiseman; Peter L Lakatos; Talat Bessissow
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

Review 5.  Management of inflammatory rheumatic conditions in the elderly.

Authors:  Clément Lahaye; Zuzana Tatar; Jean-Jacques Dubost; Anne Tournadre; Martin Soubrier
Journal:  Rheumatology (Oxford)       Date:  2019-05-01       Impact factor: 7.580

Review 6.  Controversies in Vitamin D: A Statement From the Third International Conference.

Authors:  Andrea Giustina; Roger Bouillon; Neil Binkley; Christopher Sempos; Robert A Adler; Jens Bollerslev; Bess Dawson-Hughes; Peter R Ebeling; David Feldman; Annemieke Heijboer; Glenville Jones; Christopher S Kovacs; Marise Lazaretti-Castro; Paul Lips; Claudio Marcocci; Salvatore Minisola; Nicola Napoli; Rene Rizzoli; Robert Scragg; John H White; Anna Maria Formenti; John P Bilezikian
Journal:  JBMR Plus       Date:  2020-11-10

Review 7.  How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease.

Authors:  Viviana Laredo; Carla J Gargallo-Puyuelo; Fernando Gomollón
Journal:  J Clin Med       Date:  2022-02-04       Impact factor: 4.241

8.  Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry Study.

Authors:  E L M Ter Haar; S E Thomas; J M P A van den Reek; M E Otero; M D Njoo; P M Ossenkoppele; E N Kop; S R P Dodemont; J E M Körver; A L A Kuijpers; R J Lindhout; R A Tupker; J M Mommers; M A M Berends; M I A Koetsier; M S de Bruin-Weller; M B Visch; W P Arnold; P P M van Lümig; M M Kleinpenning; S F K Lubeek; E M G J de Jong
Journal:  Drugs Aging       Date:  2022-07-21       Impact factor: 4.271

Review 9.  The elderly IBD patient in the modern era: changing paradigms in risk stratification and therapeutic management.

Authors:  Simon J Hong; Seymour Katz
Journal:  Therap Adv Gastroenterol       Date:  2021-07-03       Impact factor: 4.409

Review 10.  A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases.

Authors:  Hang Hock Shim; Pak Wo Chan; Sai Wei Chuah; Brian J Schwender; San Choon Kong; Khoon Lin Ling
Journal:  JGH Open       Date:  2018-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.